JianPiYiShen formula prevents cisplatin-induced acute kidney injury in mice by improving necroptosis through MAPK pathway.

"Declarations Ethics approval and consent to participateThe study was approved by Experimental Animal Center of Shenzhen TopBiotech Co., Ltd (Shenzhen,China). Approval number is TOP-IACUC-2022-0186. And all methods were carried out in accordance with relevant guidelines and regulations. This study was carried out in compliance with the ARRIVE guidelines. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding This research was supported by Traditional Chinese Medicine Bureau of Guangdong Province (20223015), Shenzhen Traditional Chinese Medicine Hospital “3030 Program” Chinese Medicine Clinical Research Project (G3030202111), Natural Science Foundation of Guangdong Province of China (2020A1515011151), Shenzhen Science and Technology Plan Project (JCYJ20180302173708520), and Shenzhen Fund for Guangdong Provincial High level Clinical Key Specialties."